Gene · 23523
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular disease. | BMC Nephrol | 2026 | 41735917 | PubTator, text mining | PubMed |
| Novel diagnostic approaches and therapeutic management of mucormycosis: insights from a retrospective monocentric cohort study. | Front Med (Lausanne) | 2026 | 41716808 | PubTator, text mining | PubMed |
| Pretreatment Cytokine Signatures as Candidate Biomarkers for JAK Inhibitor Response in Anti-MDA5 Dermatomyositis-Related Interstitial Lung Disease: A Pilot Study. | ACR Open Rheumatol | 2026 | 41711173 | PubTator, text mining | PubMed |
| Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea. | Lasers Surg Med | 2026 | 41668549 | PubTator, text mining | PubMed |
| Rationalized immunosuppressant dosing in kidney transplantation: Mycophenolate mofetil AUC monitoring and key updates on tacrolimus exposure. | Nefrologia (Engl Ed) | 2026 | 41654354 | PubTator, text mining | PubMed |
| Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China. | Ren Fail | 2026 | 41582001 | PubTator, text mining | PubMed |
| A Pooled Analysis of Sex Differences in Lupus Nephritis. | Kidney Int Rep | 2026 | 41541783 | PubTator, text mining | PubMed |
| Precision Medicine Program in Chinese Pediatric Patients With Sarcoma. | JCO Precis Oncol | 2026 | 41533994 | PubTator, text mining | PubMed |
| Topical therapy and vulvar malignancy risk in lichen sclerosus: a large propensity-matched study. | Am J Obstet Gynecol | 2026 | 41421748 | PubTator, text mining | PubMed |
| Steroid-sparing drugs in children and young adults with nephrotic syndrome: a target trial emulation. | Nephrol Dial Transplant | 2026 | 41042242 | PubTator, text mining | PubMed |
| Immune-mediated hepatitis requiring second-line immunosuppression: how long is required? An observational study. | Postgrad Med J | 2026 | 41025712 | PubTator, text mining | PubMed |
| Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor-Induced Kidney Fibrosis. | J Am Soc Nephrol | 2026 | 40880197 | PubTator, text mining | PubMed |
| Rare Mycobacterial Infections in Kidney Transplant Recipients - Case Reports. | Indian J Transpl | 2025 | 42465065 | PubTator, text mining | PubMed |
| Schimke immunoosseous dysplasia (SIOD): Delayed onset of rare disease and novel variant. | Qatar Med J | 2025 | 41953243 | PubTator, text mining | PubMed |
| Case Report: Rapid resolution of fever after initiation of third-line rescue treatment with upadacitinib for acute severe ulcerative colitis in two young men. | Front Gastroenterol (Lausanne) | 2025 | 41822282 | PubTator, text mining | PubMed |
| Treatment Algorithms for Inflammatory Myopathies in Adults: from Guidelines to Clinical Practice. | Curr Treatm Opt Rheumatol | 2025 | 41728064 | PubTator, text mining | PubMed |
| Calcineurin inhibitor and eltrombopag combination for acquired aplastic anemia: results from a large national database. | Ther Adv Hematol | 2025 | 41333634 | PubTator, text mining | PubMed |
| Combined Evaluation of FGF23, Klotho, Myostatin, IL-6, and IL-10 as Potential Biomarkers in Monitoring Stable Renal Transplant Recipients. | J Clin Med | 2025 | 41303166 | PubTator, text mining | PubMed |
| Unrelated Donor Age and Recipient Outcomes After Posttransplant Cyclophosphamide vs Conventional Prophylaxis. | JAMA Oncol | 2025 | 41196629 | PubTator, text mining | PubMed |
| Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman with Breast Cancer: A Case Report. | Am J Case Rep | 2025 | 41134751 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23523/papers?page=3